|
EP4074693A1
(en)
|
2011-06-08 |
2022-10-19 |
Translate Bio, Inc. |
Cleavable lipids
|
|
HRP20220070T1
(hr)
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
WO2016004318A1
(en)
*
|
2014-07-02 |
2016-01-07 |
Shire Human Genetic Therapies, Inc. |
Encapsulation of messenger rna
|
|
MX2019010155A
(es)
*
|
2017-02-27 |
2020-12-10 |
Translate Bio Inc |
Arnm de cftr optimizado por codón novedoso.
|
|
WO2018170260A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
|
US11576961B2
(en)
|
2017-03-15 |
2023-02-14 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
|
HRP20260181T1
(hr)
*
|
2017-10-20 |
2026-03-27 |
BioNTech SE |
Priprema i skladištenje lipozomskih rnk formulacija koje su pogodne za terapiju
|
|
US11939601B2
(en)
|
2017-11-22 |
2024-03-26 |
Modernatx, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
|
US11911453B2
(en)
|
2018-01-29 |
2024-02-27 |
Modernatx, Inc. |
RSV RNA vaccines
|
|
JP7256824B2
(ja)
|
2018-04-25 |
2023-04-12 |
エスリス ゲーエムベーハー |
粒子状製剤用の凍結保護剤
|
|
EP3793689A1
(en)
*
|
2018-05-15 |
2021-03-24 |
Translate Bio, Inc. |
Subcutaneous delivery of messenger rna
|
|
AU2019271215B2
(en)
|
2018-05-16 |
2024-09-12 |
Translate Bio, Inc. |
Ribose cationic lipids
|
|
US12076439B2
(en)
|
2018-05-24 |
2024-09-03 |
Translate Bio, Inc. |
Thioester cationic lipids
|
|
CN118436618A
(zh)
*
|
2018-05-30 |
2024-08-06 |
川斯勒佰尔公司 |
信使rna疫苗及其用途
|
|
MA52762A
(fr)
|
2018-05-30 |
2021-04-14 |
Translate Bio Inc |
Lipides cationiques comprenant une fraction stéroïdienne
|
|
EP3802507A1
(en)
|
2018-05-30 |
2021-04-14 |
Translate Bio, Inc. |
Vitamin cationic lipids
|
|
AU2019277355A1
(en)
|
2018-05-30 |
2020-12-17 |
Translate Bio, Inc. |
Phosphoester cationic lipids
|
|
WO2020023533A1
(en)
|
2018-07-23 |
2020-01-30 |
Translate Bio, Inc. |
Dry power formulations for messenger rna
|
|
CA3109548A1
(en)
*
|
2018-08-14 |
2020-02-20 |
Ethris Gmbh |
Lipid-based formulations containing salts for the delivery of rna
|
|
MA53443A
(fr)
*
|
2018-08-24 |
2021-12-01 |
Flagship Pioneering Innovations Vi Llc |
Paquets de messagers végétaux modifiés et utilisations associées
|
|
EP3843709A1
(en)
|
2018-08-29 |
2021-07-07 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
|
EP3849617A1
(en)
|
2018-09-14 |
2021-07-21 |
Translate Bio, Inc. |
Composition and methods for treatment of methylmalonic acidemia
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
CN112996854B
(zh)
|
2018-09-19 |
2024-08-30 |
摩登纳特斯有限公司 |
高纯度peg脂质和其用途
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
DK3864163T3
(da)
|
2018-10-09 |
2024-05-06 |
Univ British Columbia |
Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
|
|
CN112888451A
(zh)
|
2018-10-19 |
2021-06-01 |
川斯勒佰尔公司 |
信使rna的无泵包封
|
|
KR102860605B1
(ko)
|
2018-11-09 |
2025-09-15 |
트랜슬레이트 바이오 인코포레이티드 |
에스테르, 티오에스테르, 이황화물, 및 무수물 모이어티가 삽입된 2,5-디옥소피페라진
|
|
US20220016265A1
(en)
|
2018-11-09 |
2022-01-20 |
Translate Bio, Inc. |
Messenger rna therapy for treatment of ocular diseases
|
|
EP3880174A2
(en)
*
|
2018-11-12 |
2021-09-22 |
Translate Bio, Inc. |
Methods for inducing immune tolerance
|
|
WO2020146344A1
(en)
|
2019-01-07 |
2020-07-16 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
|
EP3911302B1
(en)
*
|
2019-01-17 |
2025-09-10 |
Georgia Tech Research Corporation |
Drug delivery systems containing oxidized cholesterols
|
|
CN113939282A
(zh)
*
|
2019-01-31 |
2022-01-14 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
WO2020214946A1
(en)
|
2019-04-18 |
2020-10-22 |
Translate Bio, Inc. |
Cystine cationic lipids
|
|
EP3959195B1
(en)
|
2019-04-22 |
2023-11-08 |
Translate Bio, Inc. |
Thioester cationic lipids
|
|
WO2020227085A1
(en)
|
2019-05-03 |
2020-11-12 |
Translate Bio, Inc. |
Di-thioester cationic lipids
|
|
AU2020274758B2
(en)
*
|
2019-05-14 |
2025-05-01 |
Translate Bio, Inc. |
Improved process of preparing mRNA-loaded lipid nanoparticles
|
|
EP3976593A1
(en)
|
2019-05-31 |
2022-04-06 |
Translate Bio, Inc. |
Macrocyclic lipids
|
|
WO2020257611A1
(en)
|
2019-06-21 |
2020-12-24 |
Translate Bio, Inc. |
Cationic lipids comprising an hydroxy moiety
|
|
EP3986858A1
(en)
|
2019-06-21 |
2022-04-27 |
Translate Bio, Inc. |
Tricine and citric acid lipids
|
|
CA3146369A1
(en)
*
|
2019-07-08 |
2021-01-14 |
Translate Bio, Inc. |
Improved mrna-loaded lipid nanoparticles and processes of making the same
|
|
AU2020315962B2
(en)
|
2019-07-23 |
2026-02-12 |
Translate Bio, Inc. |
Stable compositions of mRNA-loaded lipid nanoparticles and processes of making
|
|
CA3155003A1
(en)
|
2019-09-20 |
2021-03-25 |
Translate Bio, Inc. |
Mrna encoding engineered cftr
|
|
US12378560B2
(en)
|
2019-10-29 |
2025-08-05 |
Northwestern University |
Sequence multiplicity within spherical nucleic acids
|
|
MX2022007756A
(es)
|
2019-12-20 |
2022-09-27 |
Translate Bio Inc |
Suministro rectal de arn mensajero.
|
|
JP2023508881A
(ja)
*
|
2019-12-20 |
2023-03-06 |
トランスレイト バイオ, インコーポレイテッド |
Mrna担持脂質ナノ粒子を調製する改善されたプロセス
|
|
WO2021142245A1
(en)
|
2020-01-10 |
2021-07-15 |
Translate Bio, Inc. |
Compounds, pharmaceutical compositions and methods for modulating expression of muc5b in lung cells and tissues
|
|
US20230285297A1
(en)
*
|
2020-01-31 |
2023-09-14 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
|
CA3170319A1
(en)
|
2020-02-10 |
2021-08-19 |
Translate Bio, Inc. |
Methods and compositions for messenger rna purification
|
|
BR112022016258A2
(pt)
|
2020-02-18 |
2022-10-18 |
Translate Bio Inc |
Processos melhorados para transcrição in vitro de rna mensageiro
|
|
CN115427021A
(zh)
*
|
2020-02-25 |
2022-12-02 |
翻译生物公司 |
制备负载mrna的脂质纳米颗粒的改进方法
|
|
CN115667207B
(zh)
|
2020-04-01 |
2025-09-16 |
翻译生物公司 |
基于酚酸脂质的阳离子脂质
|
|
WO2021226468A1
(en)
|
2020-05-07 |
2021-11-11 |
Translate Bio, Inc. |
Improved compositions for cftr mrna therapy
|
|
AU2021269042A1
(en)
|
2020-05-07 |
2023-02-02 |
Translate Bio, Inc. |
Optimized nucleotide sequences encoding SARS-CoV-2 antigens
|
|
WO2021226463A1
(en)
|
2020-05-07 |
2021-11-11 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
|
ES3066134T3
(en)
|
2020-05-14 |
2026-05-11 |
Translate Bio Inc |
Peg lipidoid compounds
|
|
JP7873638B2
(ja)
|
2020-05-15 |
2026-06-12 |
トランスレイト バイオ, インコーポレイテッド |
mRNA送達のための脂質ナノ粒子製剤
|
|
TW202220637A
(zh)
*
|
2020-08-06 |
2022-06-01 |
美商現代公司 |
製備脂質奈米顆粒之方法
|
|
WO2022066916A1
(en)
|
2020-09-23 |
2022-03-31 |
Translate Bio, Inc. |
Piperazine-based cationic lipids
|
|
JP7844452B2
(ja)
|
2020-09-23 |
2026-04-13 |
トランスレイト バイオ, インコーポレイテッド |
Tesベースのカチオン性脂質
|
|
US12678406B2
(en)
|
2020-10-12 |
2026-07-14 |
Translate Bio Inc. |
Process of preparing ice-based lipid nanoparticles
|
|
CA3198411A1
(en)
|
2020-10-12 |
2022-04-21 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
|
MX2023004371A
(es)
|
2020-10-14 |
2023-07-26 |
George Mason Res Foundation Inc |
Lípidos ionizables, y métodos de fabricación y uso de los mismos.
|
|
WO2022099003A1
(en)
|
2020-11-06 |
2022-05-12 |
Sanofi |
Lipid nanoparticles for delivering mrna vaccines
|
|
US12576030B2
(en)
|
2020-11-09 |
2026-03-17 |
Translate Bio, Inc. |
Compositions for delivery of codon-optimized mRNA
|
|
EP4304640A1
(en)
|
2021-03-12 |
2024-01-17 |
Northwestern University |
Antiviral vaccines using spherical nucleic acids
|
|
US20250268994A1
(en)
|
2021-03-25 |
2025-08-28 |
Translate Bio, Inc. |
Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof
|
|
CA3215606A1
(en)
|
2021-04-19 |
2022-10-27 |
Shrirang KARVE |
Improved compositions for delivery of mrna
|
|
AU2022294274A1
(en)
|
2021-06-18 |
2024-02-01 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
|
EP4362920A1
(en)
|
2021-07-01 |
2024-05-08 |
Translate Bio, Inc. |
Compositions for delivery of mrna
|
|
WO2023009422A1
(en)
*
|
2021-07-26 |
2023-02-02 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to airway epithelium
|
|
EP4763287A2
(en)
|
2021-09-03 |
2026-06-24 |
CureVac SE |
Novel lipid nanoparticles for delivery of nucleic acids
|
|
EP4422698A1
(en)
|
2021-10-29 |
2024-09-04 |
CureVac SE |
Improved circular rna for expressing therapeutic proteins
|
|
US20230302112A1
(en)
|
2021-11-05 |
2023-09-28 |
Sanofi |
Respiratory synctial virus rna vaccine
|
|
JP2024545572A
(ja)
|
2021-11-10 |
2024-12-10 |
トランスレイト バイオ, インコーポレイテッド |
原発性線毛機能不全の治療のための組成物及び方法
|
|
AR127808A1
(es)
|
2021-11-30 |
2024-02-28 |
Sanofi Pasteur Inc |
Vacunas contra el metapneumovirus humano
|
|
CA3242439A1
(en)
|
2021-12-17 |
2023-06-22 |
Sanofi |
Lyme disease rna vaccine
|
|
EP4469091A1
(en)
|
2022-01-28 |
2024-12-04 |
CureVac SE |
Nucleic acid encoded transcription factor inhibitors
|
|
EP4493548A1
(en)
|
2022-03-16 |
2025-01-22 |
Translate Bio, Inc. |
Asymmetric piperazine-based cationic lipids
|
|
CN121318878A
(zh)
|
2022-04-13 |
2026-01-13 |
赛诺菲 |
基于“古德”缓冲液的阳离子脂质
|
|
WO2023214082A2
(en)
|
2022-05-06 |
2023-11-09 |
Sanofi |
Signal sequences for nucleic acid vaccines
|
|
CA3248209A1
(en)
|
2022-05-25 |
2023-11-30 |
CureVac SE |
Escherichia coli Antigenic Polypeptide-Based Nucleic Acid Vaccine (FIMH)
|
|
WO2023231959A2
(en)
|
2022-05-30 |
2023-12-07 |
Shanghai Circode Biomed Co., Ltd |
Synthetic circular rna compositions and methods of use thereof
|
|
US12297285B2
(en)
|
2022-06-24 |
2025-05-13 |
Orna Therapeutics, Inc. |
Circular RNA encoding chimeric antigen receptors targeting BCMA
|
|
EP4565209A1
(en)
|
2022-08-04 |
2025-06-11 |
Sanofi Pasteur Inc. |
Quantitative assessment of rna encapsulation
|
|
JP2025529906A
(ja)
|
2022-08-22 |
2025-09-09 |
ザ ヘンリー エム ジャクソン ファンデイション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド |
コロナウイルスに対するワクチン
|
|
US20240108545A1
(en)
|
2022-10-03 |
2024-04-04 |
West Pharmaceutical Services, Inc. |
Methods and adapters for mixing pharmaceutical complexes
|
|
WO2024089638A1
(en)
|
2022-10-28 |
2024-05-02 |
Glaxosmithkline Biologicals Sa |
Nucleic acid based vaccine
|
|
KR20250099727A
(ko)
|
2022-11-04 |
2025-07-02 |
사노피 파스퇴르 인크 |
호흡기 세포융합 바이러스 rna 백신접종
|
|
TW202428289A
(zh)
|
2022-11-08 |
2024-07-16 |
美商歐納醫療公司 |
環狀rna組合物
|
|
AU2023394992A1
(en)
|
2022-12-15 |
2025-07-31 |
Sanofi Pasteur Inc. |
Mrna encoding influenza virus-like particle
|
|
TW202438514A
(zh)
|
2022-12-20 |
2024-10-01 |
法商賽諾菲公司 |
鼻病毒mrna疫苗
|
|
WO2024160826A1
(en)
|
2023-01-31 |
2024-08-08 |
BioNTech SE |
Compositions and methods
|
|
AR132053A1
(es)
|
2023-03-02 |
2025-05-21 |
Sanofi Pasteur |
Composiciones para su uso en el tratamiento de clamidia
|
|
KR20250153298A
(ko)
|
2023-03-08 |
2025-10-24 |
큐어백 에스이 |
핵산 전달을 위한 신규의 지질 나노입자 제형
|
|
IL324411A
(en)
|
2023-05-05 |
2026-01-01 |
Sanofi Pasteur Inc |
Preparations for use in the treatment of acne
|
|
US20250009865A1
(en)
|
2023-05-10 |
2025-01-09 |
Sanofi |
Combination respiratory mrna vaccines
|
|
WO2024230934A1
(en)
|
2023-05-11 |
2024-11-14 |
CureVac SE |
Therapeutic nucleic acid for the treatment of ophthalmic diseases
|
|
JP2026524781A
(ja)
|
2023-06-12 |
2026-07-24 |
サノフイ |
芳香族頭部基を有するトリシン及びクエン酸系カチオン性脂質
|
|
MX2025015001A
(es)
|
2023-06-12 |
2026-02-03 |
Sanofi Sa |
Lipidos cationicos basados en tricina y acido citrico
|
|
JP2026524780A
(ja)
|
2023-06-12 |
2026-07-24 |
サノフイ |
芳香族頭部基を有するステロール系カチオン性脂質
|
|
JP2026524354A
(ja)
|
2023-06-28 |
2026-07-22 |
サノフィ ワクチンズ ユーエス インコーポレイテッド |
核酸送達のためのジアンヒドロヘキシトール系イオン化可能な脂質
|
|
JP2026524414A
(ja)
|
2023-06-28 |
2026-07-22 |
サノフィ ワクチンズ ユーエス インコーポレイテッド |
核酸送達のためのヘルパー脂質
|
|
WO2025003760A1
(en)
|
2023-06-28 |
2025-01-02 |
Sanofi |
Sterol analogs in lipid nanoparticle formulations
|
|
IL325951A
(en)
|
2023-07-19 |
2026-03-01 |
Sanofi Sa |
Porphyromonas gingivalis antigenic constructs
|
|
TW202527960A
(zh)
|
2023-09-06 |
2025-07-16 |
美商賽諾菲巴斯德公司 |
經修飾b型流感血球凝集素多肽及核酸及其用途
|
|
EP4780812A1
(en)
|
2023-09-20 |
2026-07-29 |
Sanofi |
Good" buffer-based cationic lipids for nucleic acid delivery
|
|
US12599560B2
(en)
|
2023-11-02 |
2026-04-14 |
Longuide Biopharma Corporation |
Lipids and lipid nanoparticle formulations
|
|
WO2025091377A1
(en)
*
|
2023-11-02 |
2025-05-08 |
Longuide Biopharma Corporation |
Lipids and lipid nanoparticle formulations
|
|
WO2025101862A1
(en)
|
2023-11-08 |
2025-05-15 |
Axelyf ehf. |
Single domain antibody binders of myc
|
|
WO2025104351A1
(en)
|
2023-11-17 |
2025-05-22 |
Sanofi Pasteur Inc. |
Hplc-based assays for detecting multiple mrna constructs
|
|
WO2025117969A1
(en)
|
2023-12-01 |
2025-06-05 |
Orna Therapeutics, Inc. |
Process for manufacturing lipid nanoparticles
|
|
WO2025134071A1
(en)
|
2023-12-22 |
2025-06-26 |
Sanofi |
Malic and glutaric acid based ionizable lipids
|
|
AU2024412236A1
(en)
|
2023-12-28 |
2026-07-09 |
Fujifilm Corporation |
Method for delivering nucleic acid to immune cells, agent for delivering nucleic acid to immune cells, and use thereof
|
|
WO2025141521A1
(en)
|
2023-12-29 |
2025-07-03 |
Sanofi |
Lipids having dendritic moieties
|
|
WO2025166238A1
(en)
|
2024-01-31 |
2025-08-07 |
Orna Therapeutics, Inc. |
Fast-shedding polyethylene glycol lipids
|
|
WO2025196065A1
(en)
|
2024-03-20 |
2025-09-25 |
Sanofi |
Novel homocysteine based lipids and their use for delivery of nucleic acids
|
|
WO2025210592A1
(en)
|
2024-04-05 |
2025-10-09 |
Sanofi Pasteur Inc. |
Muscle cell lnp-mrna quality control assays
|
|
WO2025261607A1
(en)
|
2024-06-21 |
2025-12-26 |
BioNTech SE |
Particles, compositions and methods
|
|
WO2026006524A2
(en)
|
2024-06-26 |
2026-01-02 |
Sanofi Pasteur Inc. |
Bis-ester and amide cationic lipids
|
|
WO2026003373A1
(en)
|
2024-06-28 |
2026-01-02 |
Sanofi |
Phenolic acid lipid based cationic lipids
|
|
WO2026008743A1
(en)
|
2024-07-02 |
2026-01-08 |
Sanofi Pasteur Inc. |
Water-soluble polyanionic polymer as adjuvant for carrier-formulated nucleic acid
|
|
WO2026027730A1
(en)
|
2024-07-31 |
2026-02-05 |
Sanofi |
Modified h5 influenza hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2026033123A1
(en)
|
2024-08-08 |
2026-02-12 |
Sanofi Pasteur Inc. |
Lipid nanoparticle formulations for mrna delivery
|
|
WO2026053147A1
(en)
|
2024-09-05 |
2026-03-12 |
Sanofi Pasteur Inc. |
Helper lipids and lnp compositions comprising same
|
|
WO2026052773A1
(en)
|
2024-09-06 |
2026-03-12 |
Sanofi |
Modified influenza a hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2026094020A1
(en)
|
2024-11-04 |
2026-05-07 |
Sanofi Pasteur Inc. |
Phthalic acid and vanillic acid based cationic lipids
|
|
WO2026101699A1
(en)
*
|
2024-11-08 |
2026-05-15 |
R.P. Scherer Technologies, Llc |
Lipid nanoparticle formulations, and methods of use thereof
|
|
WO2026104670A1
(en)
|
2024-11-15 |
2026-05-21 |
Sanofi Pasteur |
Variants of epstein-barr virus glycoprotein b, nucleic acids encoding the same, and uses thereof
|
|
WO2026112284A1
(en)
|
2024-11-20 |
2026-05-28 |
President And Fellows Of Harvard College |
Lipid particles for delivering rna vaccines
|
|
WO2026122418A1
(en)
|
2024-12-02 |
2026-06-11 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2026143002A2
(en)
|
2024-12-23 |
2026-07-02 |
Sanofi Pasteur Inc. |
Dianhydrohexitol based ionizable lipids for nucleic acid delivery
|
|
WO2026142992A1
(en)
|
2024-12-23 |
2026-07-02 |
Sanofi Pasteur Inc. |
Lipid nanoparticle formulations
|
|
WO2026153419A1
(en)
*
|
2025-01-16 |
2026-07-23 |
Suzhou Abogen Biosciences Co., Ltd. |
Lipid nanoparticle compositions and processes of preparing the same
|
|
WO2026165320A1
(en)
|
2025-01-31 |
2026-08-06 |
Sanofi Vaccines US Inc. |
Morpholino cationic lipids
|
|
WO2026165530A1
(en)
|
2025-02-03 |
2026-08-06 |
Renagade Therapeutics Management Inc. |
Hydrophilic polymer lipids for use in lipid nanoparticles
|